Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,226,467,754
-
Total 13F shares
-
260,482,164
-
Share change
-
+6,432,971
-
Total reported value
-
$12,615,636,311
-
Put/Call ratio
-
47%
-
Price per share
-
$48.43
-
Number of holders
-
617
-
Value change
-
+$348,221,649
-
Number of buys
-
277
-
Number of sells
-
248
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q4 2022
As of 31 Dec 2022,
Sanofi - Common Stock and American Depositary Receipts (SNY) was held by
617 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
260,482,164 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, Boston Partners, Fisher Asset Management, LLC, BlackRock Inc., BANK OF AMERICA CORP /DE/, MORGAN STANLEY, Camber Capital Management LP, Invesco Ltd., and Bank of New York Mellon Corp.
This page lists
627
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.